Population screening for cancer
142 results
1 - 100
Population screening for cancer - Essentials
- Benefits and harms
- Screening programmes recommended to be included in a public health policy
- Screening programmes that have a known effect on mortality but not yet recommended to be included in a public health policy
- Screening programmes not recommended to be included in a public health policy
- References
Screening tests for endometrial cancer in the general population- Cytology versus HPV testing for cervical cancer screening in the general population
HPV-based screening can replace cytology-based screening for cervical cancer- Consequences of screening for lung cancer (NELSON)
- Colon cancer screening may be beneficial for Lynch syndrome
- Screening for ovarian cancer with CA-125/ultrasound algorithm does not reduce mortality (UKCTOCS)
- Screening for colorectal cancer using the faecal occult blood test, Hemoccult
- Colorectal cancer screening modalities: variable uptake, variable yield (SAVE)
- USPSTF 2017 recommends against screening for thyroid cancer in asymptomatic adults (D recommendation)
- FIT more acceptable with better detection rate than gFOBT for colorectal cancer screening
- USPSTF 2018 recommends against screening for ovarian cancer in asymptomatic women (D recommendation)
- USPSTF 2019 recommends against screening for pancreatic cancer in asymptomatic adults (D recommendation)
- New screening test for nasopharyngeal cancer accurate but not proven to improve patient outcomes
- Limited benefit for routine cervical cancer screening with co-testing versus HPV testing alone
- Human papillomavirus (HPV) infection
- Interventions to encourage uptake of cancer screening for people with severe mental illness
- PSA test in prostate cancer screening
- Even before the new guidelines, a majority of women stated a preference for breast cancer screening in their 40s
- Fecal DNA testing = Hemoccult Sensa for colon cancer screening
- The full truth about prostate cancer screening is suppressed again (ERSPC)
- Results of fecal immunochemical tests for colorectal cancer screening not affected by NSAIDs, aspirin, or anticoagulants
- Have the USPSTF recommendations against screening caused more aggressive prostate cancer?
- Screening for nasopharyngeal cancer
- Pedigree identifies hereditary breast cancer syndromes
- Colon cancer screening with fecal immunochemical tests: False-positive rates vary
- Cell-free DNA blood test 83% sensitive for colorectal cancer, 13% sensitive for advanced adenoma; mortality data lacking (ECLIPSE)
- Screening programmes for the early detection and prevention of oral cancer
- Supplemental MRI screening in women with very dense breasts reduces interval cancer rate but may cause overdiagnosis (DENSE)
- Lung cancer screening requires additional imaging in 40% of patients in real world
- Health monitoring in the elderly
- Women with normal Pap smears in their 50s unlikely to develop cervical cancer as they age
- Strategies for increasing the participation of women in community breast cancer screening
- Regular self‐examination or clinical examination for early detection of breast cancer
- Screening for breast cancer: False-positive rates 60% over 10 years
- Uncertain risks and benefits of CT screening for lung cancer
- Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults
- Screening for lung cancer
- Lung cancer screening with low-dose CT does not affect smoking cessation rates
- Self examination for breast cancer
- Guaiac‐based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average‐risk individuals
- Screening for reducing morbidity and mortality in malignant melanoma
- Impact of low‐dose computed tomography (LDCT) screening on lung cancer‐related mortality
- Observation = radical prostatectomy for most pts with localized prostate cancer (PIVOT)
- Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk
- Low cost versus other screening tests to detect cervical cancer or precancer in developing countries
- Colorectal neoplasia yield similar for FIT every 1, 2 or 3 years
- Subsequent colon cancer is rare in older patients with polyps
- Markov model: colonoscopy is most effective strategy in improving outcomes
- Better estimate of prostate cancer risk based on the number of close relatives with prostate cancer and their age at diagnosis
- Systematic screening and assessment of psychosocial well‐being and care needs of people with cancer
- Combined ultrasound + mammogram for high-risk women increases cancer yield
- Helicobacter pylori eradication for the prevention of gastric neoplasia
- Negative colonoscopy result predicts no colon cancer for more than 10 years
- Problems of childhood or adolescence cancer survivors in adulthood
- Colon CA unlikely if unexplained anemia but ferritin >100 ng/mL
- Training health workers in clinical breast examination for early detection of breast cancer in low‐ and middle‐income countries
- Severe fatigue after treatment for childhood cancer
- Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals
- FIT has similar yield as colonoscopy for colorectal cancer and advanced adenoma over 10 years
- Human papillomavirus testing versus conventional cytology for cytological cervical lesions
- Hereditary susceptibility to cancer
- Postcoital bleeding of limited use in determining cervical cancer risk
- Prostate cancer
- Invitation to a single colonoscopy has only modest impact on colorectal cancer incidence (NordICC)
- Personalised risk communication for informed decision making about taking screening tests: Cochrane systematic review